⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

Official Title: Phase II, Randomized, Controlled, Clinical Trial Exploring Efficacy and Safety of ERY001 (L-asparaginase Encapsulated in Red Blood Cells) in Association With Gemcitabine or FOLFOX4 in Second-line Therapy for Patients With Progressive Metastatic Pancreatic Carcinoma

Study ID: NCT02195180

Study Description

Brief Summary: A new approach that aims to destroy pancreatic tumor cells through modification of the tumor environment. Asparagine synthetase (ASNS) is an enzyme wich synthetise asparagine. Asparagine is an essential nutriment for pancreatic cancer cells which have no or low level of ASNS. by L-asparaginase encapsulated in erythrocytes deplete (supress) Plasma asparagine. in selected patients having no or low ASNS, may provide a new therapeutic approach.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Saint Catherine Institute, Avignon, , France

Institut de Cancerologie, Brest, , France

Hopital Beaujon, Clichy, , France

Hospital Henri Mondor, Creteil, , France

Groupe Hospitalier Mutualiste Grenoble, Grenoble, , France

Centre Hospitalier Departemental Vendee - Les Oudairies, La Roche-sur-Yon, , France

Centre Oscar Lambret, Lille, , France

Cnetre Leon Berard, Lyon, , France

Institut Regional du Cancer-Montpellier Val d'Aurelle, Montpellier, , France

Institute Mutualiste Montsouris, Paris, , France

Hospital Saint Antoine, Paris, , France

Hospital Pitie Salpetriere, Paris, , France

CHU de Poitiers, Poitiers, , France

CHU Reims, Reims, , France

CHU Toulouse - Rangueil, Toulouse, , France

CHU de Tours, Tours, , France

Contact Details

Name: Pascal Hammel, Pr MD

Affiliation: Hopital Beaujon

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: